Hypertension Drugs and Skin Cancer Risk Highlights SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. Millennials Rely on Internet for Information, Providers for Cancer Treatment Decisions

Patients with cancer and caregivers said that the internet helped them to make informed care-related decisions. Read more.

4. PBM Acquisition Allows Diplomat Pharmacy Inc. to Expand Patient-Centric Offerings

Diplomat Pharmacy Inc.’s Acquisition of National Pharmaceutical Services will improve patient management services. Read more.

3. Tisagenlecleucel Elicits Complete Response in Diffuse Large B-Cell Lymphoma Patients

Tisagenlecleucel (Kymriah) produced an overall response rate of 53% in patients with lymphoma. Read more.

2. No Relief from High Drug Costs in Sight

Prescription drug list prices outpaced the rate of inflation every year from 2006 to 2015. Read more.

1. Anti-Hypertensives May Increase the Risk of Skin Cancer

Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma. Read more.

Related Videos
cancer pain management | Image Credits: © Burlingham - stock.adobe.com
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
3d rendered illustration of lung cancer 3D illustration - Image credit:  appledesign | stock.adobe.com
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.